249 results
Page 8 of 13
424B5
qz877ocgche35a
17 Jan 14
Prospectus supplement for primary offering
12:00am
424B5
yj9mpk
17 Jan 14
Prospectus supplement for primary offering
12:00am
8-K
EX-5.1
29wxlk0xv2qty
16 Oct 13
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
p8o1vmbnab5nrfb0yo9
16 Oct 13
Entry into a Material Definitive Agreement
12:00am
424B5
calfd bdulaeo4a
15 Oct 13
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
4hch0 dfl
29 Aug 13
Rexahn Pharmaceuticals Announces Teva will not Exercise its Option to License RX-3117
12:00am
424B5
6vp1c1o4wu1wsu
24 Jul 13
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
f9ih6g050admc
15 Jul 13
Rexahn Pharmaceuticals Announce IND Submission for RX-3117
12:00am
8-K
EX-10.1
pbj9cv9 hioz
29 Mar 13
Departure of Directors or Certain Officers
12:00am
8-K
EX-99.1
i4vbyur g2kd
30 Nov 12
Rexahn Pharmaceuticals Prices Public Offering of Stock
12:00am
424B5
p6kpm
30 Nov 12
Prospectus supplement for primary offering
12:00am
8-K
EX-1.1
dxqlkaptnjl
30 Nov 12
Rexahn Pharmaceuticals Prices Public Offering of Stock
12:00am
424B5
8g5w74u579i
29 Nov 12
Prospectus supplement for primary offering
12:00am